{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:33:19Z","timestamp":1791304399819,"version":"4.3.1"},"reference-count":38,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2017,4,29]]},"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Gorlin syndrome (GS) is an autosomal dominant syndrome characterised by multiple basal cell carcinomas (BCCs) and an increased risk of jaw cysts and early childhood medulloblastoma. Heterozygous germline variants in\n                      <jats:italic>PTCH1<\/jats:italic>\n                      and\n                      <jats:italic>SUFU<\/jats:italic>\n                      encoding components of the Sonic hedgehog pathway explain the majority of cases. Here, we aimed to delineate genotype\u2013phenotype correlations in GS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We assessed genetic and phenotypic data for 182 individuals meeting the diagnostic criteria for GS (median age: 47.1; IQR: 31.1\u201361.1). A total of 126 patients had a heterozygous pathogenic variant, 9 had\n                      <jats:italic>SUFU<\/jats:italic>\n                      pathogenic variants and 46 had no identified mutation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients with variants were more likely to be diagnosed earlier (p=0.02), have jaw cysts (p=0.002) and have bifid ribs (p=0.003) or any skeletal abnormality (p=0.003) than patients with no identified mutation. Patients with a missense variant in\n                      <jats:italic>PTCH1<\/jats:italic>\n                      were diagnosed later (p=0.03) and were less likely to develop at least 10 BCCs and jaw cysts than those with other pathogenic\n                      <jats:italic>PTCH1<\/jats:italic>\n                      variants (p=0.03). Patients with\n                      <jats:italic>SUFU<\/jats:italic>\n                      pathogenic variants were significantly more likely than those with\n                      <jats:italic>PTCH1<\/jats:italic>\n                      pathogenic variants to develop a medulloblastoma (p=0.009), a meningioma (p=0.02) or an ovarian fibroma (p=0.015), but were less likely to develop a jaw cyst (p=0.0004).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      We propose that the clinical heterogeneity of GS can in part be explained by the underlying or\n                      <jats:italic>SUFU<\/jats:italic>\n                      variant.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jmedgenet-2017-104669","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T21:00:26Z","timestamp":1496955626000},"page":"530-536","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":84,"title":["First evidence of genotype\u2013phenotype correlations in Gorlin syndrome"],"prefix":"10.1136","volume":"54","author":[{"given":"D Gareth","family":"Evans","sequence":"first","affiliation":[{"name":"Division of Evolution and Genomic Science, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK"},{"name":"Manchester Centre for Genomic Medicine, St Mary\u2019s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deemesh","family":"Oudit","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Oncology Christie Hospital, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam J","family":"Smith","sequence":"additional","affiliation":[{"name":"Division of Evolution and Genomic Science, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK"},{"name":"Manchester Centre for Genomic Medicine, St Mary\u2019s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rutkowski","sequence":"additional","affiliation":[{"name":"Division of Evolution and Genomic Science, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK"},{"name":"Department of Dermatology, MAHSC, Salford Royal Foundation Trust, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Allan","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Oncology Christie Hospital, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G","family":"Newman","sequence":"additional","affiliation":[{"name":"Division of Evolution and Genomic Science, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK"},{"name":"Manchester Centre for Genomic Medicine, St Mary\u2019s Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK"},{"name":"Department of Dermatology, MAHSC, Salford Royal Foundation Trust, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T","family":"Lear","sequence":"additional","affiliation":[{"name":"Department of Dermatology, MAHSC, Salford Royal Foundation Trust, Salford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,6,8]]},"reference":[{"key":"2025101713024742000_54.8.530.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196005052621803"},{"key":"2025101713024742000_54.8.530.2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33139"},{"key":"2025101713024742000_54.8.530.3","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M"},{"key":"2025101713024742000_54.8.530.4","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320500312"},{"key":"2025101713024742000_54.8.530.5","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.30.6.460"},{"key":"2025101713024742000_54.8.530.6","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.34128"},{"key":"2025101713024742000_54.8.530.7","doi-asserted-by":"publisher","DOI":"10.1097\/01.GIM.0000145045.17711.1C"},{"key":"2025101713024742000_54.8.530.8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/217378","article-title":"Basal cell carcinomas in Gorlin syndrome: a review of 202 patients","volume":"2011","author":"Jones","year":"2011","journal-title":"J Skin Cancer"},{"key":"2025101713024742000_54.8.530.9","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1991.435"},{"key":"2025101713024742000_54.8.530.10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.7258"},{"key":"2025101713024742000_54.8.530.11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11537"},{"key":"2025101713024742000_54.8.530.12","first-page":"472","article-title":"Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas","volume":"146","author":"Schofield","year":"1995","journal-title":"Am J Pathol"},{"key":"2025101713024742000_54.8.530.13","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197710)40:4+<1861::AID-CNCR2820400815>3.0.CO;2-9"},{"key":"2025101713024742000_54.8.530.14","doi-asserted-by":"publisher","DOI":"10.3109\/02688699109002890"},{"key":"2025101713024742000_54.8.530.15","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90868-4"},{"key":"2025101713024742000_54.8.530.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81268-4"},{"key":"2025101713024742000_54.8.530.17","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5268.1668"},{"key":"2025101713024742000_54.8.530.18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.2569"},{"key":"2025101713024742000_54.8.530.19","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.32944"},{"key":"2025101713024742000_54.8.530.20","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2007.055343"},{"key":"2025101713024742000_54.8.530.21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10689-013-9623-1","article-title":"Frameshift mutation in the PTCH2 gene can cause nevoid basal cell carcinoma syndrome","volume":"12","author":"Fujii","year":"2013","journal-title":"Fam Cancer"},{"key":"2025101713024742000_54.8.530.22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10689-014-9712-9","article-title":"Intronic splicing mutations in PTCH1 cause Gorlin syndrome","volume":"13","author":"Bholah","year":"2014","journal-title":"Fam Cancer"},{"key":"2025101713024742000_54.8.530.23","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/ped.12461","article-title":"Gorlin syndrome (nevoid basal cell carcinoma syndrome): update and literature review","volume":"56","author":"Fujii","year":"2014","journal-title":"Pediatr Int"},{"key":"2025101713024742000_54.8.530.24","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2006.047753"},{"key":"2025101713024742000_54.8.530.25","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/cge.12007","article-title":"Mutation type and position varies between mosaic and inherited NF2 and correlates with disease severity","volume":"83","author":"Evans","year":"2013","journal-title":"Clin Genet"},{"key":"2025101713024742000_54.8.530.26","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/bjd.12458","article-title":"Molecular evidence of type 2 mosaicism in Gorlin syndrome","volume":"169","author":"Torrelo","year":"2013","journal-title":"Br J Dermatol"},{"key":"2025101713024742000_54.8.530.27","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ng.3651","article-title":"Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas","volume":"48","author":"Clark","year":"2016","journal-title":"Nat Genet"},{"key":"2025101713024742000_54.8.530.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.02.004"},{"key":"2025101713024742000_54.8.530.29","doi-asserted-by":"publisher","DOI":"10.1038\/nature11329"},{"key":"2025101713024742000_54.8.530.30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.5728"},{"key":"2025101713024742000_54.8.530.31","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-012-9548-0"},{"key":"2025101713024742000_54.8.530.32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/jamadermatol.2015.4233","article-title":"Multiple hereditary infundibulocystic basal cell Carcinoma syndrome Associated with a germline SUFU mutation","volume":"152","author":"Schulman","year":"2016","journal-title":"JAMA Dermatol"},{"key":"2025101713024742000_54.8.530.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2012.07.015"},{"key":"2025101713024742000_54.8.530.34","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20385"},{"key":"2025101713024742000_54.8.530.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2014.04.001"},{"key":"2025101713024742000_54.8.530.36","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.35.6.450"},{"key":"2025101713024742000_54.8.530.37","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2015-103290"},{"key":"2025101713024742000_54.8.530.38","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/dds370"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmedgenet-2017-104669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:02:52Z","timestamp":1760731372000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmedgenet-2017-104669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,8]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,7,25]]},"published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1136\/jmedgenet-2017-104669"],"URL":"https:\/\/doi.org\/10.1136\/jmedgenet-2017-104669","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,8]]}}}